GlassScriptPhysician profile
Kei Yamada
NPI 1487895959
$154,349.10
in general payments reported to CMS, 2019-2025
26 companies · $12K in 2025
The $12K reported for 2025 was more than what 90% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,156 · 2020: $1,803 · 2021: $9,073 · 2022: $23K · 2023: $60K · 2024: $41K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $59K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $43K · Travel and Lodging: $6,506 · Food and Beverage: $5,071.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $58,570.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $43,485.00 |
| Travel and Lodging | $6,506.42 |
| Food and Beverage | $5,070.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Instylla, INC. | $73,829.10 | 2021-2025 | Instylla Delivery Kit, Instylla Microcatheter |
| Cook Incorporated | $60,690.22 | 2019-2025 | Rosch-Uchida, Micropuncture, Cook Celect |
| W. L. Gore & Associates, INC. | $6,532.70 | 2024-2025 | Viatorr Endoprosthesis, Viatorr Tips Endoprosthesis W/ Controlled Expansion, Gore Viatorr Tips Endoprosthesis With Controlled Expansion |
| Cook Medical LLC | $5,933.36 | 2019-2025 | Rosch-Uchida, Cook Celect, Zenith |
| Penumbra, INC. | $2,229.26 | 2023-2025 | Indigo System, Ruby Coil |
| Boston Scientific Corporation | $1,301.75 | 2023-2025 | Obsidio, Spyglass Discover, Icefx Cryoablation System |
| Microvention, INC. | $800.00 | 2023 | |
| Inari Medical, INC. | $755.26 | 2023-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Terumo Medical Corporation | $531.56 | 2022-2024 | Azur Cx Detachable, Glidesheath Slender |
| Medtronic, INC. | $411.18 | 2023-2024 | Emprint, Pipeline, Abre |
| Angiodynamics, INC. | $329.28 | 2023-2025 | Smart Port Ct, Alphavac, Micro Access |
| Trisalus Life Sciences, INC. | $182.94 | 2022-2023 | Trinav Infusion System |
| Balt USA, LLC | $145.98 | 2021 | |
| Stryker Corporation | $120.64 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit, Flowtriever |
| Bard Peripheral Vascular, INC. | $111.05 | 2024 | Covera |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiva Medical, INC. | $80.67 | 2024-2025 | Cardiva Vascade 6/7f Vcs, Savvywire |
| Sirtex Medical INC | $68.14 | 2019-2024 | Sir-Spheres Microspheres |
| Imperative Care, INC | $54.13 | 2025 | Symphony Catheter |
| Canon Medical Systems USA, INC. | $51.75 | 2024 | Interventional Angiography System |
| Route 92 Medical, INC. | $44.44 | 2024-2025 | 8f Base Camp Sheath System |
| Clinical Technology, INC | $41.15 | 2024-2025 | Vascular Product |
| Medtronic Vascular, INC. | $34.56 | 2019 | |
| Merit Medical Systems INC | $26.51 | 2025 | Merit S-Mak Kits, Embocath Plus Microcatheter |
| Becton, Dickinson and Company | $22.50 | 2025 | Denali Vena Cava Filter |
| Samsung Hme America, INC. | $20.97 | 2024 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kei Yamada listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.